Cargando…

Management of patients with intermediate-risk early stage cervical cancer

Detalles Bibliográficos
Autor principal:	Cibula, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189079/ https://www.ncbi.nlm.nih.gov/pubmed/32266803 http://dx.doi.org/10.3802/jgo.2020.31.e54

Ejemplares similares

Special Issue: “Management of Early Stage Cervical Cancer”
por: Certelli, Camilla, et al.
Publicado: (2023)

Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
por: Yu, Hao, et al.
Publicado: (2016)

A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors
por: Fu, Chunli, et al.
Publicado: (2023)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Who should be offered non-radical surgery for early-stage cervical cancer?
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2015)

Risk Stratification of Early‐Stage Cervical Cancer with Intermediate‐Risk Factors: Model Development and Validation Based on Machine Learning Algorithm
por: Chu, Ran, et al.
Publicado: (2021)

Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery
por: Cibula, David, et al.
Publicado: (2020)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

Impact of different therapies on the survival of patients with stage I–IIA cervical cancer with intermediate risk factors
por: Nie, Jichan, et al.
Publicado: (2021)

Management of patients with intermediate stage hepatocellular carcinoma
por: Prince, David, et al.
Publicado: (2020)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

High- or Intermediate-Risk Histologic Features in Patients with Clinical Early-Stage Cervical Cancer Planned for Fertility-Sparing Surgery: A Systematic Review
por: Wolswinkel, Janneke T., et al.
Publicado: (2023)

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2020)

Demonstration of Patients Illustrating Intermediate and Final Stages in the Treatment of Cervical Caries
por: Cameron, Charles
Publicado: (1929)

100% 5-Year Survival Rate in Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer is an Achievable Task
por: Chua, Peng Teng, et al.
Publicado: (2020)

Laparoscopy versus laparotomy for the management of early stage cervical cancer
por: Wang, Yan-zhou, et al.
Publicado: (2015)

Management of Early-Stage Cervical Cancer: A Literature Review
por: Guimarães, Yasmin Medeiros, et al.
Publicado: (2022)

Intermediate phenotypes underlying osteosarcoma risk
por: Semmes, Eleanor C., et al.
Publicado: (2018)

Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application
por: Guani, Benedetta, et al.
Publicado: (2022)

Relevance of pathologic features in risk stratification for early-stage endometrial cancer
por: Guerra, Esther, et al.
Publicado: (2021)

Is the Barcelona Clinic Liver Cancer guideline for treating intermediate to advanced staged hepatocellular carcinoma still appropriate?
por: Kang, Koo Jeong, et al.
Publicado: (2021)

Are patients and physicians willing to accept less-radical procedures for cervical cancer?
por: Gungorduk, Kemal, et al.
Publicado: (2018)

Erratum: Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application
Publicado: (2023)

Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis
por: Tuscharoenporn, Thunwipa, et al.
Publicado: (2023)

Therapy option for early-stage lung cancer in nonsurgical patients
por: Safi, Seyer, et al.
Publicado: (2022)

The association among cervical, anal, and oral HPV infections in high-risk and low-risk women
por: Sehnal, Borek, et al.
Publicado: (2019)

Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer
por: Lee, Tae Yeon, et al.
Publicado: (2013)

Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision
por: Cohn, David E.
Publicado: (2014)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

The path forward in early-stage lung cancer
por: Cuppens, Kristof, et al.
Publicado: (2022)

PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023)

Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study
por: Kocian, Roman, et al.
Publicado: (2020)

Negative impact of the COVID-19 pandemic on the management of cervical cancer patients in Zambia
por: Lombe, Dorothy, et al.
Publicado: (2020)

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
por: Taguchi, Ayumi, et al.
Publicado: (2023)

Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?
por: Imterat, Majdi, et al.
Publicado: (2021)

The Treatment of Aortic Valve Stenosis in Intermediate and Low-Risk Patients—When, How and Where
por: Ribichini, Flavio L., et al.
Publicado: (2022)

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Proteomic alterations in early stage cervical cancer
por: Güzel, Coşkun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_16c2e1g08jmh7p5r8tgbk59qse